Variant of TREM2 Associated with the Risk of Alzheimer's Disease

Jonsson, Thorlakur, Stefansson, Hreinn, Steinberg, Stacy, Jonsdottir, Ingileif, Jonsson, Palmi V., Snaedal, Jon, Bjornsson, Sigurbjorn, Huttenlocher, Johanna, Levey, Allan I., Lah, James J., Rujescu, Dan, Hampel, Harald, Giegling, Ina, Andreassen, Ole A., Engedal, Knut, Ulstein, Ingun, Djurovic, Srdjan, Ibrahim-Verbaas, Carla, Hofman, Albert, Ikram, M. Arfan, van Duijn, Cornelia M, Thorsteinsdottir, Unnur, Kong, Augustine, Stefansson, Kari·2013·New England Journal of Medicine

Cited by (435)

Items 201–300 of 435

  1. TREM2 in the pathogenesis of AD: a lipid metabolism regulator and potential metabolic therapeutic target
    Li, Rui-Yang, Qin, Qi, Yang, Han-Chen, Wang, Ying-Ying, Mi, Ying-Xin, Yin, Yun-Si, Wang, Meng, Yu, Chao-Ji, Tang, Yi · 2022 · Molecular Neurodegeneration
  2. TREM2 shedding by cleavage at the H157‐S158 bond is accelerated for the Alzheimer's disease‐associated H157Y variant
    Thornton, Peter, Sevalle, Jean, Deery, Michael J, Fraser, Graham, Zhou, Ye, Ståhl, Sara, Franssen, Elske H, Dodd, Roger B, Qamar, Seema, Gomez Perez‐Nievas, Beatriz et al. · 2017 · EMBO Molecular Medicine
  3. Effects of Multiple Genetic Loci on Age at Onset in Late-Onset Alzheimer Disease: A Genome-Wide Association Study
    Naj, Adam C., Jun, Gyungah, Reitz, Christiane, Kunkle, Brian W., Perry, William, Park, Yo Son, Beecham, Gary W., Rajbhandary, Ruchita A., Hamilton-Nelson, Kara L., Wang, Li-San et al. · 2014 · JAMA Neurology
  4. Plaque-associated human microglia accumulate lipid droplets in a chimeric model of Alzheimer’s disease
    Claes, Christel, Danhash, Emma Pascal, Hasselmann, Jonathan, Chadarevian, Jean Paul, Shabestari, Sepideh Kiani, England, Whitney E., Lim, Tau En, Hidalgo, Jorge Luis Silva, Spitale, Robert C., Davtyan, Hayk et al. · 2021 · Molecular Neurodegeneration
  5. Insights into TREM2 biology by network analysis of human brain gene expression data
    Forabosco, Paola, Ramasamy, Adaikalavan, Trabzuni, Daniah, Walker, Robert, Smith, Colin, Bras, Jose, Levine, Adam P., Hardy, John, Pocock, Jennifer M., Guerreiro, Rita et al. · 2013 · Neurobiology of Aging
  6. TREM2 ameliorates neuroinflammatory response and cognitive impairment via PI3K/AKT/FoxO3a signaling pathway in Alzheimer’s disease mice
    Wang, Yaping, Lin, Yan, Wang, Linhan, Zhan, Hongrui, Luo, Xiaoting, Zeng, Yanyan, Wu, Wen, Zhang, Xingmei, Wang, Fang · 2020 · Aging
  7. Next generation transcriptomics and genomics elucidate biological complexity of microglia in health and disease
    Wes, Paul D., Holtman, Inge R., Boddeke, Erik W.G.M., Möller, Thomas, Eggen, Bart J.L. · 2016 · Glia
  8. TREM2 dependent and independent functions of microglia in Alzheimer’s disease
    Hou, Jinchao, Chen, Yun, Grajales-Reyes, Gary, Colonna, Marco · 2022 · Molecular Neurodegeneration
  9. TREM2 deficiency reduces the efficacy of immunotherapeutic amyloid clearance
    Xiang, Xianyuan, Werner, Georg, Bohrmann, Bernd, Liesz, Arthur, Mazaheri, Fargol, Capell, Anja, Feederle, Regina, Knuesel, Irene, Kleinberger, Gernot, Haass, Christian · 2016 · EMBO Molecular Medicine
  10. Targeting microglia for the treatment of Alzheimer’s Disease
    Wes, Paul D., Sayed, Faten A., Bard, Frédérique, Gan, Li · 2016 · Glia
  11. NEBULA is a fast negative binomial mixed model for differential or co-expression analysis of large-scale multi-subject single-cell data
    He, Liang, Davila-Velderrain, Jose, Sumida, Tomokazu S., Hafler, David A., Kellis, Manolis, Kulminski, Alexander M. · 2021 · Communications Biology
  12. Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer’s disease
    Dionisio-Santos, Dawling A., Olschowka, John A., O’Banion, M. Kerry · 2019 · Journal of Neuroinflammation
  13. Contribution to Alzheimer's disease risk of rare variants in TREM2, SORL1, and ABCA7 in 1779 cases and 1273 controls
    Bellenguez, Céline, Charbonnier, Camille, Grenier-Boley, Benjamin, Quenez, Olivier, Le Guennec, Kilan, Nicolas, Gaël, Chauhan, Ganesh, Wallon, David, Rousseau, Stéphane, Richard, Anne Claire et al. · 2017 · Neurobiology of Aging
  14. Axonal Degeneration during Aging and Its Functional Role in Neurodegenerative Disorders
    Salvadores, Natalia, Sanhueza, Mario, Manque, Patricio, Court, Felipe A. · 2017 · Frontiers in Neuroscience
  15. TREM2 in CNS homeostasis and neurodegenerative disease
    Painter, Meghan M., Atagi, Yuka, Liu, Chia-Chen, Rademakers, Rosa, Xu, Huaxi, Fryer, John D., Bu, Guojun · 2015 · Molecular Neurodegeneration
  16. Variant TREM2 as Risk Factor for Alzheimer's Disease
    Neumann, Harald, Daly, Mark J. · 2013 · New England Journal of Medicine
  17. White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease
    Araque Caballero, Miguel Ángel, Suárez-Calvet, Marc, Duering, Marco, Franzmeier, Nicolai, Benzinger, Tammie, Fagan, Anne M, Bateman, Randall J, Jack, Clifford R, Levin, Johannes, Dichgans, Martin et al. · 2018 · Brain
  18. Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer’s disease
    Landel, Véréna, Baranger, Kévin, Virard, Isabelle, Loriod, Béatrice, Khrestchatisky, Michel, Rivera, Santiago, Benech, Philippe, Féron, François · 2014 · Molecular Neurodegeneration
  19. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice
    Jiang, Teng, Zhang, Ying-Dong, Chen, Qi, Gao, Qing, Zhu, Xi-Chen, Zhou, Jun-Shan, Shi, Jian-Quan, Lu, Huan, Tan, Lan, Yu, Jin-Tai · 2016 · Neuropharmacology
  20. Association between genetic traits for immune-mediated diseases and Alzheimer disease
    Yokoyama, Jennifer S., Wang, Yunpeng, Schork, Andrew J., Thompson, Wesley K., Karch, Celeste M., Cruchaga, Carlos, McEvoy, Linda K., Witoelar, Aree, Chen, Chi-Hua, Holland, Dominic et al. · 2016 · JAMA Neurology
  21. Young microglia restore amyloid plaque clearance of aged microglia
    Daria, Anna, Colombo, Alessio, Llovera, Gemma, Hampel, Heike, Willem, Michael, Liesz, Arthur, Haass, Christian, Tahirovic, Sabina · 2017 · The EMBO Journal
  22. PU.1 regulates Alzheimer’s disease-associated genes in primary human microglia
    Rustenhoven, Justin, Smith, Amy M., Smyth, Leon C., Jansson, Deidre, Scotter, Emma L., Swanson, Molly E. V., Aalderink, Miranda, Coppieters, Natacha, Narayan, Pritika, Handley, Renee et al. · 2018 · Molecular Neurodegeneration
  23. A 3D Alzheimer's disease culture model and the induction of P21-activated kinase mediated sensing in iPSC derived neurons
    Zhang, Dawei, Pekkanen-Mattila, Mari, Shahsavani, Mansoureh, Falk, Anna, Teixeira, Ana I., Herland, Anna · 2014 · Biomaterials
  24. Directed evolution of adeno-associated virus for efficient gene delivery to microglia
    Lin, Rui, Zhou, Youtong, Yan, Ting, Wang, Ruiyu, Li, Heng, Wu, Zhaofa, Zhang, Xinshuang, Zhou, Xiangyu, Zhao, Fei, Zhang, Li et al. · 2022 · Nature Methods
  25. The Trem2 R47H Alzheimer's risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans
    Xiang, Xianyuan, Piers, Thomas M., Wefers, Benedikt, Zhu, Kaichuan, Mallach, Anna, Brunner, Bettina, Kleinberger, Gernot, Song, Wilbur, Colonna, Marco, Herms, Jochen et al. · 2018 · Molecular Neurodegeneration
  26. Nuclear Receptors License Phagocytosis by Trem2+Myeloid Cells in Mouse Models of Alzheimer's Disease
    Savage, Julie C., Jay, Taylor, Goduni, Elanda, Quigley, Caitlin, Mariani, Monica M., Malm, Tarja, Ransohoff, Richard M., Lamb, Bruce T., Landreth, Gary E. · 2015 · The Journal of Neuroscience
  27. Progress and promise in understanding the genetic basis of common diseases
    Price, Alkes L., Spencer, Chris C. A., Donnelly, Peter · 2015 · Proceedings of the Royal Society B: Biological Sciences
  28. The new genetic landscape of Alzheimer’s disease: from amyloid cascade to genetically driven synaptic failure hypothesis?
    Dourlen, Pierre, Kilinc, Devrim, Malmanche, Nicolas, Chapuis, Julien, Lambert, Jean-Charles · 2019 · Acta Neuropathologica
  29. APOE‐modulated Aβ‐induced neuroinflammation in Alzheimer's disease: current landscape, novel data, and future perspective
    Tai, Leon M., Ghura, Shivesh, Koster, Kevin P., Liakaite, Vaiva, Maienschein‐Cline, Mark, Kanabar, Pinal, Collins, Nicole, Ben‐Aissa, Manel, Lei, Arden Zhengdeng, Bahroos, Neil et al. · 2015 · Journal of Neurochemistry
  30. Microglia and Astrocyte Function and Communication: What Do We Know in Humans?
    Garland, Emma F., Hartnell, Iain J., Boche, Delphine · 2022 · Frontiers in Neuroscience
  31. Gene-environment interactions in Alzheimer's disease: A potential path to precision medicine
    Eid, Aseel, Mhatre, Isha, Richardson, Jason R. · 2019 · Pharmacology & Therapeutics
  32. Proximal recolonization by self-renewing microglia re-establishes microglial homeostasis in the adult mouse brain
    Zhan, Lihong, Krabbe, Grietje, Du, Fei, Jones, Ian, Reichert, Meredith C., Telpoukhovskaia, Maria, Kodama, Lay, Wang, Chao, Cho, Seo-hyun, Sayed, Faten et al. · 2019 · PLOS Biology
  33. TREM2 is associated with the risk of Alzheimer's disease in Spanish population
    Benitez, Bruno A., Cooper, Breanna, Pastor, Pau, Jin, Sheng-Chih, Lorenzo, Elena, Cervantes, Sebastian, Cruchaga, Carlos · 2013 · Neurobiology of Aging
  34. YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer’s disease and other tauopathies
    Querol-Vilaseca, Marta, Colom-Cadena, Martí, Pegueroles, Jordi, San Martín-Paniello, Carla, Clarimon, Jordi, Belbin, Olivia, Fortea, Juan, Lleó, Alberto · 2017 · Journal of Neuroinflammation
  35. Human Induced Pluripotent Stem Cell-Derived Microglia-Like Cells Harboring TREM2 Missense Mutations Show Specific Deficits in Phagocytosis
    Garcia-Reitboeck, Pablo, Phillips, Alexandra, Piers, Thomas M., Villegas-Llerena, Claudio, Butler, Matt, Mallach, Anna, Rodrigues, Celia, Arber, Charles E., Heslegrave, Amanda, Zetterberg, Henrik et al. · 2018 · Cell Reports
  36. Genetics ignite focus on microglial inflammation in Alzheimer’s disease
    Malik, Manasi, Parikh, Ishita, Vasquez, Jared B., Smith, Conor, Tai, Leon, Bu, Guojun, LaDu, Mary Jo, Fardo, David W., Rebeck, G. William, Estus, Steven · 2015 · Molecular Neurodegeneration
  37. Prion-like transmission of neuronal huntingtin aggregates to phagocytic glia in the Drosophila brain
    Pearce, Margaret M. P., Spartz, Ellen J., Hong, Weizhe, Luo, Liqun, Kopito, Ron R. · 2015 · Nature Communications
  38. Prostaglandin signaling suppresses beneficial microglial function in Alzheimer’s disease models
    Johansson, Jenny U., Woodling, Nathaniel S., Wang, Qian, Panchal, Maharshi, Liang, Xibin, Trueba-Saiz, Angel, Brown, Holden D., Mhatre, Siddhita D., Loui, Taylor, Andreasson, Katrin I. · 2015 · Journal of Clinical Investigation
  39. Microglial TYROBP/DAP12 in Alzheimer's Disease: Transduction of Physiological and Pathological Signals Across TREM2
    Haure-Mirande, Jean-Vianney, Audrain, Mickael, Ehrlich, Michelle E., Gandy, Sam · 2022 · Molecular Neurodegeneration
  40. A novel compound heterozygous mutation in TREM2 found in a Turkish frontotemporal dementia-like family
    Guerreiro, Rita, Bilgic, Basar, Guven, Gamze, Brás, José, Rohrer, Jonathan, Lohmann, Ebba, Hanagasi, Hasmet, Gurvit, Hakan, Emre, Murat · 2013 · Neurobiology of Aging
  41. TREM2 interacts with TDP-43 and mediates microglial neuroprotection against TDP-43-related neurodegeneration
    Xie, Manling, Liu, Yong U., Zhao, Shunyi, Zhang, Lingxin, Bosco, Dale B., Pang, Yuan-Ping, Zhong, Jun, Sheth, Udit, Martens, Yuka A., Zhao, Na et al. · 2022 · Nature Neuroscience
  42. A rare mutation in UNC5C predisposes to late-onset Alzheimer's disease and increases neuronal cell death
    Alzheimer's Disease Genetics Consortium, Wetzel-Smith, Monica K, Hunkapiller, Julie, Bhangale, Tushar R, Srinivasan, Karpagam, Maloney, Janice A, Atwal, Jasvinder K, Sa, Susan M, B Yaylaoglu, Murat, Foreman, Oded et al. · 2014 · Nature Medicine
  43. Brain somatic mutations observed in Alzheimer’s disease associated with aging and dysregulation of tau phosphorylation
    Park, Jun Sung, Lee, Junehawk, Jung, Eun Sun, Kim, Myeong-Heui, Kim, Il Bin, Son, Hyeonju, Kim, Sangwoo, Kim, Sanghyeon, Park, Young Mok, Mook-Jung, Inhee et al. · 2019 · Nature Communications
  44. TREM 2 Protein Expression Changes Correlate with Alzheimer's Disease Neurodegenerative Pathologies in Post‐Mortem Temporal Cortices
    Lue, Lih‐Fen, Schmitz, Christopher T., Serrano, Geidy, Sue, Lucia I., Beach, Thomas G., Walker, Douglas G. · 2015 · Brain Pathology
  45. TREM2 Function in Alzheimer’s Disease and Neurodegeneration
    Ulrich, Jason D., Holtzman, David M. · 2016 · ACS Chemical Neuroscience
  46. TREM2 is associated with increased risk for Alzheimer’s disease in African Americans
    Jin, Sheng Chih, Carrasquillo, Minerva M, Benitez, Bruno A, Skorupa, Tara, Carrell, David, Patel, Dwani, Lincoln, Sarah, Krishnan, Siddharth, Kachadoorian, Michaela, Reitz, Christiane et al. · 2015 · Molecular Neurodegeneration
  47. Biomarkers used in Alzheimer’s disease diagnosis, treatment, and prevention
    Mahaman, Yacoubou Abdoul Razak, Embaye, Kidane Siele, Huang, Fang, Li, Longfei, Zhu, Feiqi, Wang, Jian-Zhi, Liu, Rong, Feng, Jun, Wang, Xiaochuan · 2022 · Ageing Research Reviews
  48. Microglia limit the expansion of β-amyloid plaques in a mouse model of Alzheimer’s disease
    Zhao, Ruohe, Hu, Wanling, Tsai, Julia, Li, Wei, Gan, Wen-Biao · 2017 · Molecular Neurodegeneration
  49. Dysregulated phosphoinositide 3-kinase signaling in microglia: shaping chronic neuroinflammation
    Chu, Erskine, Mychasiuk, Richelle, Hibbs, Margaret L., Semple, Bridgette D. · 2021 · Journal of Neuroinflammation
  50. Molecular basis for the loss-of-function effects of the Alzheimer’s disease-associated R47H variant of the immune receptor TREM2
    Sudom, Athena, Talreja, Santosh, Danao, Jean, Bragg, Eric, Kegel, Rob, Min, Xiaoshan, Richardson, Jason, Zhang, Zhongqi, Sharkov, Nikolai, Marcora, Edoardo et al. · 2018 · Journal of Biological Chemistry
  51. Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease
    Giraldo, Margarita, Lopera, Francisco, Siniard, Ashley L., Corneveaux, Jason J., Schrauwen, Isabelle, Carvajal, Julian, Muñoz, Claudia, Ramirez-Restrepo, Manuel, Gaiteri, Chris, Myers, Amanda J. et al. · 2013 · Neurobiology of Aging
  52. Rare coding mutations identified by sequencing of Alzheimer disease genome‐wide association studies loci
    Vardarajan, Badri N., Ghani, Mahdi, Kahn, Amanda, Sheikh, Stephanie, Sato, Christine, Barral, Sandra, Lee, Joseph H., Cheng, Rong, Reitz, Christiane, Lantigua, Rafael et al. · 2015 · Annals of Neurology
  53. Post-mortem analysis of neuroinflammatory changes in human Alzheimer’s disease
    Gomez-Nicola, Diego, Boche, Delphine · 2015 · Alzheimer's Research & Therapy
  54. CD33: increased inclusion of exon 2 implicates the Ig V-set domain in Alzheimer’s disease susceptibility
    Raj, T., Ryan, K. J., Replogle, J. M., Chibnik, L. B., Rosenkrantz, L., Tang, A., Rothamel, K., Stranger, B. E., Bennett, D. A., Evans, D. A. et al. · 2014 · Human Molecular Genetics
  55. If amyloid drives Alzheimer disease, why have anti-amyloid therapies not yet slowed cognitive decline?
    Haass, Christian, Selkoe, Dennis · 2022 · PLOS Biology
  56. Lifestyle Modifications and Nutritional Interventions in Aging-Associated Cognitive Decline and Alzheimer's Disease
    Bhatti, Gurjit Kaur, Reddy, Arubala P., Reddy, P. Hemachandra, Bhatti, Jasvinder Singh · 2020 · Frontiers in Aging Neuroscience
  57. Human iPSC‐derived microglia: A growing toolset to study the brain's innate immune cells
    Hasselmann, Jonathan, Blurton‐Jones, Mathew · 2020 · Glia
  58. Stem cell models of Alzheimer’s disease: progress and challenges
    Arber, Charles, Lovejoy, Christopher, Wray, Selina · 2017 · Alzheimer's Research & Therapy
  59. Microglial complement receptor 3 regulates brain Aβ levels through secreted proteolytic activity
    Czirr, Eva, Castello, Nicholas A., Mosher, Kira I., Castellano, Joseph M., Hinkson, Izumi V., Lucin, Kurt M., Baeza-Raja, Bernat, Ryu, Jae Kyu, Li, Lulin, Farina, Sasha N. et al. · 2017 · Journal of Experimental Medicine
  60. A unifying hypothesis for Alzheimer's disease: from plaques to neurodegeneration
    Edwards, Frances A. · 2019 · Trends in Neurosciences
  61. Potassium Channel Kv1.3 Is Highly Expressed by Microglia in Human Alzheimer's Disease
    Rangaraju, Srikant, Gearing, Marla, Jin, Lee-Way, Levey, Allan · 2015 · Journal of Alzheimer's Disease
  62. Higher CSF sTREM2 and microglia activation are associated with slower rates of beta-amyloid accumulation
    Ewers, Michael, Biechele, Gloria, Suárez‐Calvet, Marc, Sacher, Christian, Blume, Tanja, Morenas‐Rodriguez, Estrella, Deming, Yuetiva, Piccio, Laura, Cruchaga, Carlos, Kleinberger, Gernot et al. · 2020 · EMBO Molecular Medicine
  63. Imbalance of microglial TLR4/TREM2 in LPS-treated APP/PS1 transgenic mice: a potential Link between Alzheimer's disease and systemic inflammation
    Zhou, Jian, Yu, Weihua, Zhang, Man, Tian, Xin, Li, Yu, Lü, Yang · 2019 · Neurochemical Research
  64. Drug development for alzheimer’s disease: Microglia induced neuroinflammation as a target
    Dong, Yuan, Li, Xiaoheng, Cheng, Jinbo, Hou, Lin · 2019 · International Journal of Molecular Sciences
  65. A locked immunometabolic switch underlies TREM2 R47H loss of function in human iPSC-derived microglia
    Piers, Thomas M., Cosker, Katharina, Mallach, Anna, Johnson, Gabriel Thomas, Guerreiro, Rita, Hardy, John, Pocock, Jennifer M. · 2020 · The FASEB Journal
  66. GWAS of longitudinal amyloid accumulation on18F-florbetapir PET in Alzheimer’s disease implicates microglial activation gene IL1RAP
    Ramanan, Vijay K, Risacher, Shannon L., Nho, Kwangsik, Kim, Sungeun, Shen, Li, McDonald, Brenna C., Yoder, Karmen K., Hutchins, Gary D., West, John D., Tallman, Eileen F. et al. · 2015 · Brain
  67. DAP12 stabilizes the C-terminal fragment of the triggering receptor expressed on myeloid cells-2 (TREM2) and protects against LPS-induced pro-inflammatory response
    Zhong, Li, Chen, Xiao-Fen, Zhang, Zhen-Lian, Wang, Zhe, Shi, Xin-Zhen, Xu, Kai, Zhang, Yun-Wu, Xu, Huaxi, Bu, Guojun · 2015 · Journal of Biological Chemistry
  68. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
    DESGESCO (Dementia Genetics Spanish Consortium), EADB (Alzheimer Disease European DNA biobank), van der Lee, Sven J., EADB (Alzheimer Disease European DNA biobank), IFGC (International FTD-Genomics Consortium), IPDGC (The International Parkinson Disease Genomics Consortium), IPDGC (The International Parkinson Disease Genomics Consortium), RiMod-FTD (Risk and Modifying factors in Fronto-Temporal Dementia), Netherlands Brain Bank (NBB), The GIFT (Genetic Investigation in Frontotemporal Dementia and Alzheimer’s Disease) Study Group, Conway, Olivia J., Jansen, Iris et al. · 2019 · Acta Neuropathologica
  69. Microglia-Mediated Neuroprotection, TREM2, and Alzheimer’s Disease: Evidence From Optical Imaging
    Condello, Carlo, Yuan, Peng, Grutzendler, Jaime · 2018 · Biological Psychiatry
  70. Apolipoprotein E4 impairs the response of neurodegenerative retinal microglia and prevents neuronal loss in glaucoma
    Margeta, Milica A., Yin, Zhuoran, Madore, Charlotte, Pitts, Kristen M., Letcher, Sophia M., Tang, Jing, Jiang, Shuhong, Gauthier, Christian D., Silveira, Sebastian R., Schroeder, Caitlin M. et al. · 2022 · Immunity
  71. Developing Effective Alzheimer’s Disease Therapies: Clinical Experience and Future Directions
    Elmaleh, David R., Farlow, Martin R., Conti, Peter S., Tompkins, Ronald G., Kundakovic, Ljiljana, Tanzi, Rudolph E. · 2019 · Journal of Alzheimer’s Disease
  72. ATP-binding cassette transporter A7 (ABCA7) loss of function alters Alzheimer amyloid processing
    Satoh, Kanayo, Abe-Dohmae, Sumiko, Yokoyama, Shinji, St George-Hyslop, Peter, Fraser, Paul E. · 2015 · Journal of Biological Chemistry
  73. Whole-genome analyses of whole-brain data: working within an expanded search space
    Medland, Sarah E, Jahanshad, Neda, Neale, Benjamin M, Thompson, Paul M · 2014 · Nature Neuroscience
  74. The Inflammatory Continuum of Traumatic Brain Injury and Alzheimer’s Disease
    Kokiko-Cochran, Olga N., Godbout, Jonathan P. · 2018 · Frontiers in Immunology
  75. Trem2 deletion enhances tau dispersion and pathology through microglia exosomes
    Zhu, Bing, Liu, Yan, Hwang, Spring, Archuleta, Kailey, Huang, Huijie, Campos, Alex, Murad, Rabi, Piña-Crespo, Juan, Xu, Huaxi, Huang, Timothy Y. · 2022 · Molecular Neurodegeneration
  76. Differential Phagocytic Properties of CD45low Microglia and CD45high Brain Mononuclear Phagocytes—Activation and Age-Related Effects
    Rangaraju, Srikant, Raza, Syed Ali, Li, Noel Xiang’An, Betarbet, Ranjita, Dammer, Eric B., Duong, Duc, Lah, James J., Seyfried, Nicholas T., Levey, Allan I. · 2018 · Frontiers in Immunology
  77. Targeting innate immunity for neurodegenerative disorders of the central nervous system
    Andreasson, Katrin I., Bachstetter, Adam D., Colonna, Marco, Ginhoux, Florent, Holmes, Clive, Lamb, Bruce, Landreth, Gary, Lee, Daniel C., Low, Donovan, Lynch, Marina A. et al. · 2016 · Journal of Neurochemistry
  78. Opposing Effects of Membrane-Anchored CX3CL1 on Amyloid and Tau Pathologies via the p38 MAPK Pathway
    Lee, Sungho, Xu, Guixiang, Jay, Taylor R., Bhatta, Sabina, Kim, Ki-Wook, Jung, Steffen, Landreth, Gary E., Ransohoff, Richard M., Lamb, Bruce T. · 2014 · The Journal of Neuroscience
  79. Genetic architecture of Alzheimer's disease
    Neuner, Sarah M., TCW, Julia, Goate, Alison M. · 2020 · Neurobiology of Disease
  80. Homeostatic Microglia Initially Seed and Activated Microglia Later Reshape Amyloid Plaques in Alzheimer's Disease
    Baligács, Nóra, Albertini, Giulia, Borrie, Sarah C., Serneels, Lutgarde, Pridans, Clare, Balusu, Sriram, De Strooper, Bart · 2024 · Nature Communications
  81. Microglia in prion diseases
    Aguzzi, Adriano, Zhu, Caihong · 2017 · Journal of Clinical Investigation
  82. Microglial priming in Alzheimer’s disease
    Li, Jun-Wei, Zong, Yu, Cao, Xi-Peng, Tan, Lin, Tan, Lan · 2018 · Annals of Translational Medicine
  83. Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challenges
    Cano, Amanda, Turowski, Patric, Ettcheto, Miren, Duskey, Jason Thomas, Tosi, Giovanni, Sánchez-López, Elena, García, Maria Luisa, Camins, Antonio, Souto, Eliana B., Ruiz, Agustín et al. · 2021 · Journal of Nanobiotechnology
  84. Systems-based proteomics to resolve the biology of Alzheimer’s disease beyond amyloid and tau
    Rayaprolu, Sruti, Higginbotham, Lenora, Bagchi, Pritha, Watson, Caroline M., Zhang, Tian, Levey, Allan I., Rangaraju, Srikant, Seyfried, Nicholas T. · 2021 · Neuropsychopharmacology
  85. Alzheimer's Disease Mechanisms and Emerging Roads to Novel Therapeutics
    Sala Frigerio, Carlo, De Strooper, Bart · 2016 · Annual Review of Neuroscience
  86. Bapineuzumab and solanezumab for Alzheimer's disease: is the ‘amyloid cascade hypothesis’ still alive?
    Tayeb, Haythum O, Murray, Evan D, Price, Bruce H, Tarazi, Frank I · 2013 · Expert Opinion on Biological Therapy
  87. Ultrastructural evidence of microglial heterogeneity in Alzheimer’s disease amyloid pathology
    El Hajj, Hassan, Savage, Julie C., Bisht, Kanchan, Parent, Martin, Vallières, Luc, Rivest, Serge, Tremblay, Marie-Ève · 2019 · Journal of Neuroinflammation
  88. R47H TREM2 variant increases risk of typical early‐onset Alzheimer's disease but not of prion or frontotemporal dementia
    Slattery, Catherine F., Beck, Jonathan A., Harper, Lorna, Adamson, Gary, Abdi, Zeinab, Uphill, James, Campbell, Tracy, Druyeh, Ron, Mahoney, Colin J., Rohrer, Jonathan D. et al. · 2014 · Alzheimer's & Dementia
  89. Genetic variability in response to amyloid beta deposition influences Alzheimer’s disease risk
    Salih, Dervis A, Bayram, Sevinc, Guelfi, Sebastian, Reynolds, Regina H, Shoai, Maryam, Ryten, Mina, Brenton, Jonathan W, Zhang, David, Matarin, Mar, Botia, Juan A et al. · 2019 · Brain Communications
  90. Impact of TREM2 risk variants on brain region-specific immune activation and plaque microenvironment in Alzheimer's disease patient brain samples
    Prokop, Stefan, Miller, Kelly R., Labra, Sergio R., Pitkin, Rose M., Hoxha, Kevt’her, Narasimhan, Sneha, Changolkar, Lakshmi, Rosenbloom, Alyssa, Lee, Virginia M.-Y., Trojanowski, John Q. · 2019 · Acta Neuropathologica
  91. Silencing of TREM2 exacerbates tau pathology, neurodegenerative changes, and spatial learning deficits in P301S tau transgenic mice
    Jiang, Teng, Tan, Lan, Zhu, Xi-Chen, Zhou, Jun-Shan, Cao, Lei, Tan, Meng-Shan, Wang, Hui-Fu, Chen, Qi, Zhang, Ying-Dong, Yu, Jin-Tai · 2015 · Neurobiology of Aging
  92. Aging microglia
    Antignano, Ignazio, Liu, Yingxiao, Offermann, Nina, Capasso, Melania · 2023 · Cellular and Molecular Life Sciences
  93. Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia
    Ruiz, Agustín, Dols-Icardo, Oriol, Bullido, María J., Pastor, Pau, Rodríguez-Rodríguez, Eloy, López de Munain, Adolfo, de Pancorbo, Marian M., Pérez-Tur, Jordi, Álvarez, Victoria, Antonell, Anna et al. · 2014 · Neurobiology of Aging
  94. Impact of peripheral myeloid cells on amyloid-β pathology in Alzheimer’s disease–like mice
    Prokop, Stefan, Miller, Kelly R., Drost, Natalia, Handrick, Susann, Mathur, Vidhu, Luo, Jian, Wegner, Anja, Wyss-Coray, Tony, Heppner, Frank L. · 2015 · Journal of Experimental Medicine
  95. APOE genotype and sex affect microglial interactions with plaques in Alzheimer’s disease mice
    Stephen, T. L., Cacciottolo, M., Balu, D., Morgan, T. E., LaDu, M. J., Finch, C. E., Pike, C. J. · 2019 · Acta Neuropathologica Communications
  96. TREM2 ectodomain and its soluble form in Alzheimer’s disease
    Yang, Jiaolong, Fu, Zhihui, Zhang, Xingyu, Xiong, Min, Meng, Lanxia, Zhang, Zhentao · 2020 · Journal of Neuroinflammation
  97. The neuritic plaque facilitates pathological conversion of tau in an Alzheimer’s disease mouse model
    Li, Tong, Braunstein, Kerstin E., Zhang, Juhong, Lau, Ashley, Sibener, Leslie, Deeble, Christopher, Wong, Philip C. · 2016 · Nature Communications
  98. ABI3 and PLCG2 missense variants as risk factors for neurodegenerative diseases in Caucasians and African Americans
    Conway, Olivia J, Carrasquillo, Minerva M, Wang, Xue, Bredenberg, Jenny M, Reddy, Joseph S, Strickland, Samantha L, Younkin, Curtis S, Burgess, Jeremy D, Allen, Mariet, Lincoln, Sarah J et al. · 2018 · Molecular Neurodegeneration
  99. HDAC 3 negatively regulates spatial memory in a mouse model of Alzheimer's disease
    Zhu, Xiaolei, Wang, Sulei, Yu, Linjie, Jin, Jiali, Ye, Xing, Liu, Yi, Xu, Yun · 2017 · Aging Cell
  100. Opposing roles of the triggering receptor expressed on myeloid cells 2 and triggering receptor expressed on myeloid cells-like transcript 2 in microglia activation
    Zheng, Honghua, Liu, Chia-Chen, Atagi, Yuka, Chen, Xiao-Fen, Jia, Lin, Yang, Longyu, He, Wencan, Zhang, Xilin, Kang, Silvia S., Rosenberry, Terrone L. et al. · 2016 · Neurobiology of Aging